TechInvest Magazine Chats with John Melki for Their Current Magazine Issue

The article looks at our ongoing growth as an Australian biotech company and how our proprietary 3base technology has allowed us to respond to the COVID-19 pandemic, as well as accelerate global rollout of diagnostics for enterics, sexual health and a pipeline of new products.
TechInvest Magazine